Breaking News
- Alpho: The value of pharmaceutical companies will be affected by the resolution of production problems
- Denis Ferrand-Ajchenbaum Joins Exclusive Networks to Lead Global Vendor Strategy and Relationships
- Socially Responsible Investment at the Heart of CIP Saint Lucia Covid-19 Relief Bond innovation
- Dubai cancels permits for Ramadan tents in 2021
- UAE-based Gulf Islamic Investments acquires $300mln Paris property
- Tabreed, IFC to set up district cooling JV in Singapore
- Omega, Wellpro Group seal strategic alliance for Mena region
- Honda reveals all-new City and refreshed Accord
- Flag bags: Designer Judith Leiber unveils clutches decorated in GCC country colours
- Dh29 billion in cash dividends proposed by 38 listed companies for 2020
- DP World-backed freeport 'open for business' after winning UK government bid
- Global Business Forum roadshows identify new business opportunities in African markets
- AED29 billion in cash dividends proposed by 38 listed companies for 2020
- ADNOC announces removal of destination restrictions on its crude grades
- Abu Dhabi Fund for Development, Kazakhstan explore means to strengthen strategic partnership
- UN boss appointed CEO at Arabesque
- Real estate transactions in Ajman hit AED793 million in February
- Etisalat, du to use AECB’s credit reports and credit scores
- Telefónica Germany/O2 Selects MATRIXX Software for Next-Generation Monetization
- Wipro Joins World Economic Forum Initiative to Advance Racial Justice and Social Equality
- Xendit Raises US$64.6 Million Series B Led by Accel to Scale Its Digital Payments Infrastructure Ushering in a New Era of Economic Security and Reliability in Southeast Asia
- Red Fox ID and Cepton Enable Barrier-Free, High-Speed Tolling Worldwide With High Performance Lidar Based Solutions
- COVID-19 Vaccine Adjuvant Potentials of Nichi Glucan Dietary Supplement From Japan
- Kymeta and Blue Edge Global Strategic Partnership Delivers Real World SATCOM Field Training with Military Trained Specialists
- PMI Launches Free, Online Course and Tool Kit to Help Changemakers Jumpstart Project Success in Just 45 Minutes
- PierianDx Announces the Appointment of Lindsay Mateo as Chief Business Officer
- Masimo Announces CE Marking of the Rad-G™ with Temperature
- Tecnotree Posts Strong Growth in 2020 Despite Pandemic & Global Slowdown
- Octapharma: New Consensus Recommendations on Treatment of Secondary Antibody Deficiency in Patients With Haematological Malignancies
- California Walnuts to Launch Global Marketing Initiative on March 3 with Coordinated “Power of 3” Events across the Globe
- Sintavia Acquires Three Additional GE Additive Arcam A2X Electron Beam Printers
- Vifor Pharma delivers strong full year results 2020 with an EBITDA of 576 million Swiss Francs representing over 29% growth1
- Unifrax, Backed by Clearlake Capital, Announces Lithium Ion Battery Anode Technology Coming Early Next Year
- Nightingale opens physiotherapy unit at Dubai Gold & Diamond Park
- Dubai set to get Blacklane chauffeur hailing service
- Abu Dhabi's Mubadala hires banks for dual-tranche euro bonds - document
- IHC invests in Falcon CI IV LP and SpaceX
- Dubai to issue 10-year 'cultural visa' to 1,000 people around the world
- UAE hotels among 'best performers' in 2020 with 51.7% average occupancy
- THAT concept store launches its first fashion pop-up with Dubai brand BLSSD
- Alef Group launches Al Mamsha Edge
- Adnoc generates $200m in cost savings from drilling efficiencies
- Dubai Municipality confiscates huge quantities of tobacco and pan products
- Recruitment of Filipino workers to start from April 2021: Ministry of Human Resources
- UAE stocks gain Dh5b in market value
- Merger green light for Emaar Properties and Emaar Malls
- More members of Gulf Petrochemicals and Chemicals Association sign pledge to address plastic waste
- Motional Selects Ambarella CVflow® AI Vision Processors for its Driverless Vehicles
- Andersen Global Initiates Expansion Into Bermuda
- Moody's ESG Solutions Group: V.E provides Second Party Opinion on Toyota Motor Corporation's Woven Planet Bond Framework
ARTMS and Isotopia Molecular Imaging Announce Successful Multi-Curie Labeling of PSMA-11 With Cyclotron Produced 68Ga Utilizing the QUANTM Irradiation System™ and Solid Targets

ARTMS Inc. (ARTMS) and Isotopia Molecular Imaging (Isotopia) are pleased to announce the successful radiolabeling of Isotopia’s prostate cancer imaging kit product, PSMA-11, with over 2 Ci of cyclotron-produced Gallium-68 (68Ga) using ARTMS’ proprietary Quantum Irradiation System™ (QIS™) solid target system.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210119005044/en/
The specially designed Prostate-Specific Membrane Antigen (PSMA) kit for the preparation of 68Ga-PSMA-11 (a radiopharmaceutical targeting PSMA for the imaging of prostate cancer using Positron Emission Tomography (PET)) was radiolabeled with high activity cyclotron produced 68Ga following irradiation times of less than two hours. The Isotopia kit was radiolabeled with between 500 mCi and just over 2900 mCi of 68Ga following multiple successful 68Ga production runs utilizing the QIS™ and ARTMS’ high performance 68Zn solid targets. The resultant product demonstrated 6-hour stability and radiochemical purity, which met or exceeded all regulatory standards. Cyclotron produced 68Ga combined with a kit solution will give radiopharmacies near unlimited access to this diagnostic product and a cost effective solution.
“The demand for 68Ga radiolabeled products will soon exceed the supply coming from 68Ge/68Ga generators. ARTMS’ QUANTM Irradiation System™ (QIS™) allows for the high activity and high quality 68Ga production the Molecular Imaging community requires to properly serve their patients. The QIS™’ multiple-curie per hour 68Ga production is one of the few true game changers I have seen during my career in Nuclear Medicine. We are very excited to bring on-demand 68Ga doses to clinicians and patients in collaboration with our partners,” says Charles S. Conroy, Chief Executive Officer of ARTMS.
“Isotopia is focused on developing diagnostic and therapeutic tools that best serve our patients. We see 68Ga as a better diagnostic tool to pair with Lu177 treatments. Isotopia’s high activity PSMA “kit” is a major step forward in how the global imaging community diagnoses prostate cancer. Multi-dose vial preparation will allow pharmacies to provide unit doses and allow clinicians to image patients with little to no restrictions. In addition, a 5 minute preparation and more than 95% radiochemical purity will enhance efficiency and save the radiopharmacies time and money. We aim to keep introducing to the market kit-based solutions for 50 and 100mCi Generators, cyclotron produced 68Ga, and Lu177 labeling,” says Dr. Eli Shalom, CEO of Isotopia Molecular Imaging.
ARTMS recently announced the approval for its cyclotron produced 99mTc product by Health Canada. ARTMS will continue the development of cyclotron-based products including 68Ga with a focus on optimizing production potential and satisfying regulatory requirements for use in radiopharmaceutical kits.
About Prostate Cancer
Prostate cancer is the fourth most common cancer worldwide. In 2018, 1.3 million men were diagnosed with prostate cancer for the first time. Despite advances in treatments, prostate cancer still accounts for a significant number of deaths. In 2018, more than 365,000 men died from the disease. Rates of diagnosis are increasing, and the highest levels of prostate cancer are found in the US, Europe, Australia, and New Zealand.
About ARTMS
Based in Vancouver, British Columbia, Canada, ARTMS Inc. is the global leader in the development of novel technologies and products which enable the high-quality and high-yield production of the world’s most-used diagnostic imaging isotopes. ARTMS’ flagship product, the QUANTM Irradiation System™ (QIS™), enables decentralized, cost-effective, large-scale production of important medical isotopes such as gallium-68 (68Ga), zirconium-89 (89Zr), technetium-99m (99mTc) and copper-64 (64Cu) using pharmaceutical distributor and hospital-based medical cyclotrons, empowering users to control their supply chain. ARTMS commercializes these award-winning and proprietary Canadian inventions on a global basis and has the prospect of revolutionizing the nuclear medicine industry.
For more information on the QUANTM Irradiation System™ and ARTMS, please follow us on Twitter @Quantm99 and LinkedIn and visit http://www.artms.ca/.
About Isotopia
Isotopia Molecular Imaging Ltd. is a collaboration between The Metrontario Group and some of Israel's leading scientists in the field of radiopharmaceuticals. The Isotopia development team is a multidisciplinary team consisting of nuclear pharmacists, radiochemists, nuclear engineers, and physicists. The experienced Isotopia team, together with its radio-nuclear pharmacy, cyclotron facility, 177Lu production site and sterile manufacturing, are a well-established platform for development. Isotopia creates collaborations between the scientific and medical community to further develop and experiment with new markers for imaging applications and molecular therapy.
For more information on Isotopia, please visit www.isotopia.co.il.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210119005044/en/
Top News

Etihad Airways' unused plane parts to be transformed into art

ADNOC Distribution reports AED2.4 billion net profit

Emaar Development delivers property sales of Dh6.308b

Dubai’s largest bank positive about UAE equity markets in 2021
